A Pharmacogenomic Dissection of a Rosuvastatin-Induced Rhabdomyolysis Case Evokes the Polygenic Nature of Adverse Drug Reactions

Carlos Alberto Calderon-Ospina,1,* Mario Hernández-Sómerson,2,* Ana María García,1 Adriana Mejia,1 Caroll Tamayo-Agudelo,1 Paul Laissue,1 Dora Janeth Fonseca Mendoza1 1Center for Research in Genetics and Genomics-CIGGUR, GENIUROS Research Group, School of Medicine and Hea...

Descrición completa

Detalles Bibliográficos

Principais autores:	Calderon-Ospina CA, Hernández-Sómerson M, García AM, Mejia A, Tamayo-Agudelo C, Laissue P, Fonseca Mendoza DJ
Formato:	Artigo
Idioma:	Inglês
Publicado:	Dove Medical Press 2020-03-01
Series:	Pharmacogenomics and Personalized Medicine
Assuntos:	pharmacogenomics rhabdomyolysis rosuvastatin adverse drug reaction whole-exome sequencing polymorphisms.
Acceso en liña:	https://www.dovepress.com/a-pharmacogenomic-dissection-of-a-rosuvastatin-induced-rhabdomyolysis--peer-reviewed-article-PGPM
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!